The gene signature obtained by scRNA-seq of CD8 TILs from mice treated with anti–PD-L1 combined with apyrase correlated with the response to immunotherapy in patients with melanoma (55), suggesting that apyrase-elicited conditioning of the gut ecosystem has the potential to increase the response rate to ICB in patients with cancer. The gene discussed is CD274; the disease is melanoma.